Table 1.
Demographic and Clinical Characteristics of Focus-Group Participants
| Characteristic | Total (N=29) |
|---|---|
| Age (years) | |
| Mean (SD) | 43.4 (13.2) |
| Sex, n (%) | |
| Female | 21 (72.4) |
| Racial background, n (%) | |
| Black or African American | 6 (20.7) |
| White | 19 (65.5) |
| Othera | 4 (13.8) |
| Relationship status, n (%) | |
| Single/living alone | 14 (48.3) |
| Married | 4 (13.8) |
| Partnership/cohabiting | 3 (10.3) |
| Divorced or separated | 5 (17.2) |
| Otherb | 3 (10.3) |
| Employment status, n (%) | |
| Employed full-time | 11 (37.9) |
| Employed part-time | 7 (24.1) |
| Unable to work due to disability | 5 (17.2) |
| Otherc | 6 (20.7) |
| Highest level of education, n (%) | |
| Secondary/high school | 1 (3.4) |
| Some college/university | 7 (24.1) |
| College degree | 15 (51.7) |
| Postgraduate degree | 3 (10.3) |
| Otherd | 3 (10.3) |
| Time since MDD diagnosis (years) | |
| Mean (SD) | 13.1 (10.0) |
| Median (range) | 10.8 (1–41) |
| Number of MDD episodes in the past 2 years | |
| Mean (SD) | 4.9 (4.6) |
| Median (range) | 3 (1–20) |
| Comorbidities occurring in ≥10% of participants, n (%)e | |
| Anxiety | 21 (72.4) |
| Allergies | 13 (44.8) |
| Chronic pain | 9 (31.0) |
| High cholesterol | 9 (31.0) |
| Arthritis | 8 (27.6) |
| Osteoarthritis | 7 (24.1) |
| Hypertension | 5 (17.2) |
| Hyperthyroidism | 5 (17.2) |
| Asthma | 4 (13.8) |
| Diabetes mellitus | 4 (13.8) |
| Cardiovascular | 3 (10.3) |
| None | 3 (10.3) |
| Treatments received by ≥10% of participants, n (%)f | |
| Bupropion | 12 (41.4) |
| Escitalopram | 10 (34.5) |
| Sertraline | 10 (34.5) |
| Fluoxetine | 7 (24.1) |
| Venlafaxine | 5 (17.2) |
| Clonazepam | 5 (17.2) |
| Trazodone | 4 (13.8) |
| Quetiapine | 3 (10.3) |
Notes: aOther racial background: Asian (n=1), Middle Eastern (n=1), missing (n=2); bother relationship status: living with room-mates (n=2); missing (n=1); cother employment status: missing/not specified (n=5), retired (n=1); dother highest level of education: missing (n=3); eother comorbidities: chronic obstructive pulmonary disease/emphysema (n=2), migraine (n=2), hypothyroidism, human immunodeficiency virus, irritable bowel syndrome, kidney disease, lupus, multiple sclerosis, sleep apnea (all n=1); fother medications: citalopram, duloxetine, desvenlafaxine, alprazolam, aripiprazole (all n=2), fluvoxamine, paroxetine, zolpidem, gabapentin, lithium, melatonin, mirtazapine, brexpiprazole, topiramate (all n=1).
Abbreviations: MDD, major depressive disorder; SD, standard deviation.